The Medical University of Graz and the FFG K1 center “CBmed” (Center for Biomarker Research in Medicine) provide a unique PhD Program “AMBRA“(Advanced medical biomarker research) for challenging interrelated research topics and a training program focusing on translational topics between medicine, health care and industry to highly talented and well educated students. The scientific concept includes all stages of strategic medical biomarker development ranging from the identification of new biomarkers to the validation and finally to translational research that will bring candidate biomarkers into clinical practice. AMBRA has a clear focus on the most common diseases that pose a major health threat to individuals and to the public such as cancer, metabolic, fertility and cardiovascular diseases, autoimmune as well as inflammatory, brain and ageing-related disorders.
Admitted PhD students receive funding for three years. Applicants must hold a Master´s degree or equivalent in Medicine, Chemistry or Life Sciences. English is the language used for teaching, communication and writing of the Thesis and thus, excellent English skills are required.
